Psychosocial Phone Counseling Aids Cervical Cancer Survivors

This article originally appeared here.
Share this content:
Psychosocial Phone Counseling Aids Cervical Cancer Survivors
Psychosocial Phone Counseling Aids Cervical Cancer Survivors

WEDNESDAY, March 11, 2015 (HealthDay News) -- A psychosocial telephone counseling (PTC) intervention can be beneficial for cervical cancer survivors, according to a study published online Feb. 23 in the Journal of Clinical Oncology.

Lari Wenzel, Ph.D., from the University of California at Irvine, and colleagues examined the effect of a PTC intervention on quality of life (QOL) in 204 survivors of cervical cancer who were at least nine and less than 30 months from diagnosis. Participants (mean age, 43 years; 40 percent Hispanic, 51 percent non-Hispanic white) were randomized to PTC, which included five weekly sessions and a one-month booster, or usual care (UC).

The researchers found that, compared with UC participants, those receiving PTC had significantly improved depression and improved gynecologic and cancer-specific concerns at four months (all P < 0.05), after adjustment for age and baseline scores. The significant differences in gynecologic and cancer-specific concerns persisted at nine months (P < 0.05). The longitudinal change in overall QOL and anxiety was not statistically significant. Significantly greater improvement in QOL was seen for those with decreasing interleukin (IL)-4, IL-5, IL-10, and IL-13, compared to those with increasing cytokine levels.

"This trial confirms that PTC benefits mood and QOL cancer-specific and gynecologic concerns for a multiethnic underserved population of survivors of cancer," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »